1. Potential pathogenic mechanisms underlying Fragile X Tremor Ataxia Syndrome: RAN translation and/or RNA gain-of-function?
- Author
-
Chantal Sellier, Renate K. Hukema, Rob Willemsen, Manon Boivin, Centre for Integrative Biology - CBI (Inserm U964 - CNRS UMR7104 - IGBMC), Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Erasmus University Medical Center [Rotterdam] (Erasmus MC), Dieterle, Stéphane, and Clinical Genetics
- Subjects
0301 basic medicine ,MESH: Ataxia ,[SDV]Life Sciences [q-bio] ,MESH: Neurons ,MESH: Tremor ,Fragile X Mental Retardation Protein ,0302 clinical medicine ,Tremor ,MESH: Trinucleotide Repeat Expansion ,MESH: Animals ,Genetics (clinical) ,Neurons ,Fragile X Tremor/Ataxia Syndrome ,Brain ,General Medicine ,3. Good health ,Antisense RNA ,[SDV] Life Sciences [q-bio] ,Gain of Function Mutation ,Intention tremor ,medicine.symptom ,MESH: Fragile X Syndrome ,congenital, hereditary, and neonatal diseases and abnormalities ,Ataxia ,MESH: Ubiquitin ,Biology ,MESH: Fragile X Mental Retardation Protein ,03 medical and health sciences ,MESH: Brain ,Atrophy ,RAN translation ,Genetics ,medicine ,Animals ,Humans ,MESH: Gain of Function Mutation ,MESH: Humans ,Ubiquitin ,RNA ,medicine.disease ,FMR1 ,nervous system diseases ,MESH: Astrocytes ,Disease Models, Animal ,030104 developmental biology ,Astrocytes ,Fragile X Syndrome ,Gait Ataxia ,FXTAS ,MESH: Disease Models, Animal ,Trinucleotide Repeat Expansion ,RNA gain-of-function ,Neuroscience ,Microsatellite expansion ,030217 neurology & neurosurgery - Abstract
International audience; Fragile X-associated tremor/ataxia syndrome (FXTAS) is an inherited neurodegenerative disease caused by an expansion of 55-200 CGG repeats located in the FMR1 gene. The main clinical and neuropathological features of FXTAS are progressive intention tremor and gait ataxia associated with brain atrophy, neuronal cell loss and presence of ubiquitin-positive intranuclear inclusions in both neurons and astrocytes. At the molecular level, FXTAS is characterized by increased expression of FMR1 sense and antisense RNA containing expanded CGG or GGC repeats, respectively. Here, we discuss the putative molecular mechanisms underlying FXTAS and notably recent reports that expanded CGG and GGC repeats may be pathogenic through RAN translation into toxic proteins.
- Published
- 2018
- Full Text
- View/download PDF